Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)

Clinical trial NCT03315689 · COMPLETED

Trial details

NCT number: NCT03315689
Sponsor: Aclaris Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alopecia Universalis (AU)Alopecia Totalis (AT)

Start date: 2017-12-14
Primary completion: 2019-06-20
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.